Hong Kong stock anomaly | Juzi Biotech (02367.HK) surged over 6% again in the first half of the year, with sales expenses controlled beyond market expectations, leaving ample room for investment in peak seasons such as Double Eleven.
According to the Wall Street Journal app, Jubilant Life Sciences (02367.HK) has risen by over 6% again, rising by 6.12% to 63.45 Hong Kong dollars as of press time, with a trading volume of 255 million Hong Kong dollars.
Latest
4 m ago
